LifeSciences BC > News > Member Announcements

StarFish Medical named 2018 Strategic Life Sciences Partner of the Year

February 21, 2018
Starfish Medical Inc.

VICTORIA, BC – February 21, 2018 – StarFish Medical is pleased to announce that LifeSciences BC has selected the company as Strategic Life Sciences Partner of the Year.  The award is determined by the LifeSciences BC board of directors as part of the 20th Annual LifeSciences BC Awards. The annual awards recognize talented individuals and organizations … Continue reading StarFish Medical named 2018 Strategic Life Sciences Partner of the Year

2018 LifeSciences BC Annual Award Winners Announced

February 19, 2018
LifeSciences BC

VANCOUVER, BC – February 19, 2018 – LifeSciences BC is pleased to announce the recipients of the 20th Annual LifeSciences BC Awards, presented by FARRIS. These awards are presented annually to recognize talented individuals and organizations that represent the life sciences ecosystem in B.C. which includes; academia, health institutions, government and industry. The award winners … Continue reading 2018 LifeSciences BC Annual Award Winners Announced

BC-led Digital Technology Supercluster awarded federal funding

February 15, 2018
LifeSciences BC

Vancouver, British Columbia, February 15, 2018 – The British Columbia-led Digital Technology Supercluster is one of the funding recipients for the Government of Canada’s Innovation Supercluster Initiative, Minister Navdeep Bains announced today. In May 2017, Minister Bains announced a nationwide initiative to create up to five superclusters that will supercharge Canada’s regional innovation ecosystems and … Continue reading BC-led Digital Technology Supercluster awarded federal funding

Arbutus Enters Exclusivity Agreement with Roivant Sciences

February 15, 2018
Arbutus Biopharma Corporation

VANCOUVER, British Columbia and WARMINSTER, Pa., Feb. 14, 2018 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation(Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, announced today that Arbutus and Roivant entered into an exclusivity agreement (Exclusivity Agreement) providing for a period that expires on March 15, 2018. Pursuant to the Exclusivity Agreement, during this period, Arbutus and Roivant agree to negotiate … Continue reading Arbutus Enters Exclusivity Agreement with Roivant Sciences

DelMar Pharmaceuticals Announces Second Quarter Fiscal Year 2018 Financial Results

February 15, 2018
DelMar Pharmaceuticals, Inc.

Company will host a business update conference call on Tuesday, February 20, 2018 at 4:30 PM EST VANCOUVER, British Columbia and MENLO PARK, Calif., Feb. 14, 2018 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new cancer therapies, announced its financial results for the second quarter … Continue reading DelMar Pharmaceuticals Announces Second Quarter Fiscal Year 2018 Financial Results

Arbutus Announces Departure of Chief Financial Officer; Appoints Interim CFO

February 14, 2018
Arbutus Biopharma Corporation

VANCOUVER, British Columbia and WARMINSTER, Pa., Feb. 13, 2018 (GLOBE NEWSWIRE) —  Arbutus Biopharma Corporation(Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, announced today that Bruce Cousins, Executive Vice President and Chief Financial Officer, is leaving the Company but will remain available on a consulting basis. Koert VandenEnden, Arbutus’ Vice President of Finance, will serve as Interim Chief Financial … Continue reading Arbutus Announces Departure of Chief Financial Officer; Appoints Interim CFO

Aquinox Provides Enrollment Update for LEADERSHIP 301 Clinical Trial of Rosiptor

February 9, 2018
Aquinox Pharmaceuticals, Inc.

Enrollment target reached; topline data on track for Q3 2018 announcement NEW YORK, Feb. 09, 2018 (GLOBE NEWSWIRE) — Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood cancers, today announced that it has met its enrollment threshold of 300 females in its … Continue reading Aquinox Provides Enrollment Update for LEADERSHIP 301 Clinical Trial of Rosiptor

Arbutus Consolidates HBV Business Around Warminster, PA Site

February 8, 2018
Arbutus Biopharma Corporation

VANCOUVER, British Columbia and WARMINSTER, Pa., Feb. 08, 2018 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation(Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced a site consolidation and organizational restructuring to better align its HBV business in Warminster, PA. These organizational changes are expected to result in increased efficiency, a more flexible variable cost structure, and additional preservation of the … Continue reading Arbutus Consolidates HBV Business Around Warminster, PA Site

Ondine Biomedical, Inc. Announces the Appointment of Vicente Fox, Former President of Mexico (2000 – 2006) to Board of Directors

February 8, 2018
Ondine Biomedical Inc. 

Ondine Biomedical, Inc. is proud to announce the appointment of Vicente Fox, Former President of Mexico, to their board of directors. VANCOUVER, B.C. (PRWEB) FEBRUARY 08, 2018 – Ondine Biomedical Inc. today announced that Vicente Fox, Former President of Mexico (2000 – 2006) has been appointed to Ondine’s Board of Directors. Since leaving the Presidency, Mr. … Continue reading Ondine Biomedical, Inc. Announces the Appointment of Vicente Fox, Former President of Mexico (2000 – 2006) to Board of Directors

Aquinox to Present at LEERINK Partners 7th Annual Global Healthcare Conference

February 2, 2018
Aquinox Pharmaceuticals, Inc.

VANCOUVER, British Columbia, Feb. 02, 2018 (GLOBE NEWSWIRE) — Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood cancers, today announced that David Main, Aquinox President & CEO, will present a corporate overview at the upcoming LEERINK Partners7th Annual Global Healthcare Conference in New York, NY on Thursday, February 15th 2018 at 1:00 PM Eastern Time. … Continue reading Aquinox to Present at LEERINK Partners 7th Annual Global Healthcare Conference